CHICAGO — Northwestern Medicine is looking for 5,000 people at risk for contracting coronavirus to sign up for clinical trials aimed at preventing the spread of the virus.
The clinical trials run by Northwestern’s Feinberg School of Medicine are seeking people at least 18 years old working in jobs that put them at an increased risk for contracting coronavirus including health care workers, grocery and retail store employees, public transportation employees and factory workers. The registry is also seeking volunteers from racial and ethic groups disproportionately affected by COVID-19 including African Americans, Native Americans and Hispanic people with underlying health conditions.
“We want to recruit participants in the Chicago area who are at risk for exposure to COVID-19 and who are potentially interested in participating in different studies for prevention of the infection,” Dr. Karen Krueger, the principle investigator of the registry, said in a statement.
“We are casting a really wide net so we can make sure we have enough people identified and ready to go for upcoming studies. This is vital to individuals’ and community health during the coronavirus pandemic.”
The first study is set to launch in August as part of the third phase of a clinical trial investigating a vaccine drug candidate by AstraZeneca LLC. The results of the previous phases were published in The Lancet Journal. Trials are expected to be conducted at Northwestern’s downtown Chicago campus, Lake Forest Hospital and Central DuPage Hospital.
People interested in additional information can email email@example.com, call (312) 694-0414 or fill out a registry consent form online.
This article originally appeared on the Chicago Patch